Efficacy and side effects of intermittent recombinant interferon-α2a in chronic aggressive hepatitis C: With or without initial daily administration

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 8, 1996, Pages 718-723

  Itoh, Hidekazu ^a   Nakata, Hidenori ^a   Yokoya, Yukihiro ^a   Nakashima, Shoichi ^a   Yamanishi, Tetsuji ^a   Hara, Takeshi ^a   Kawai, Jun ^a   Miyamoto, Hisao ^b   Higashi, Katsuhiko ^c   Nishioka, Shingo ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Hashimoto Municipal Hospital   (Japan)

^c Hidaka General Hospital   (Japan)

Author keywords

Chronic hepatitis; Hepatitis C virus; Interferon

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTHRALGIA; ARTICLE; BONE MARROW TOXICITY; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALAISE; MALE; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 8944241765     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00320.x     Document Type: Article

References (18)

1. Hoofnagle JH, Mullen KD, Jones DB et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha Interferon. A preliminary report. N. Engl. J. Med. 1986; 315: 1575-8.
2. Thomson BL, Doran M, Lever AMI, Webster ADB. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gamma-globulin replacement therapy. Lancet 1987; i: 539-41.
3. Kakumu S, Arao M, Yoshioka K et al. Recombinant human-interferon therapy for chronic non-A, non-B hepatitis: Second report. Am. J. Gastroenterol. 1989; 85: 655-9.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
5. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
6. Davis GL, Balart LA, Schiff EF et al. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized controlled trial. N. Engl. J. Med. 1989; 321: 1501-6.
7. Di Bisceglie AM, Martin P, Kassiandies C et al. Recombinant interferon alpha therapy for chronic hepatitis C. N. Engl. J. Med. 1989; 321: 1506-10.
8. Chayama K, Saitoh S, Arase Y et al. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology 1991; 13: 1040-3.
9. Yoshida K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alpha therapy: Relation to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
10. Takada N, Takase S, Takada A. Effects of genotypes of hepatitis C virus on interferon treatment for chronic type C hepatitis. Gastroenterol. Jpn. 1993; 28: 268-75.
11. Takase S, Takada N, Sawada M et al. Effects of interferon treatment for chronic type C liver diseases with different hepatitis C virus genotypes: A co-operative study in three hospitals, Int. Hepatol. Commun. 1993; 1: 321-5.
12. Yamada G, Takahashi M, Tsuji T et al. Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C. Dig. Dis. Sci. 1992; 37: 1926-7.
13. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus in serum during interferon alpha therapy. Gastroenterology 1993; 104: 877-83.
14. Toyoda H, Nakano S, Kumada T et al. Clinical study of efficacy of interferon a for chronic hepatitis C: Evaluation according to effectiveness and background. Acta Hepatol. Jpn. 1994; 35: 481-7.
15. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
16. Kato N, Yokosuka O, Hosoda K, Itoh Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
17. De Groote J, Desmet VJ, Gedigk P et al. Classification of chronic hepatitis. Lancet 1968; ii: 626-8.
18. Itoh H, Nishioka S, Nakata H et al. Prevalence of antihepatitis C virus antibody in patients with alcoholic liver diseases. Wakayama Med. Rep. 1993; 34: 63-70.